Companies / Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc.

Nasdaq: TARSCIK 1819790IRVINE, CA

Financials · FY2025

Revenue$451.36M
Net income$-66.42M
Total debt$72.76M
Cash$204.59M
Diluted EPS$-1.59
Shares outstanding43.9M

Ownership

43.9M shares outstanding · as of Jul 30, 2026
6.9%10%+ / strategic
Ownership
10%+ / strategic6.89%3,024,945
Institutions100.65%44,169,308
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 11

View all →
Insider% of sharesShares
Link William J PhdFormerDirector
0.24%106,786
Neervannan SeshadriFormerChief Operating Officer
0.19%82,791
Wahl BryanFormerGeneral Counsel
0.15%63,959
Mottiwala AzizFormerChief Commercial Officer
0.14%61,480
Farrow Jeffrey SFormerSee Remarks
0.10%43,316
Whitfield Dianne C.FormerChief Human Resources Officer
0.08%35,028
Azamian Bobak R.CEOFormerPresident/CEO and Board Chair · Director
0.08%33,421
Lin Elizabeth YeuFormerChief Medical Officer
0.05%23,308
Yarno Wendy LFormerDirector
0.04%16,654
Goodrich KatherineFormerDirector
<0.01%2,233

Institutional holders 255

View all →
HolderValue% of shares
RTW Investments, LP$273.10M7.60%
Deep Track Capital, LP$245.97M6.85%
BlackRock, Inc.$242.71M8.79%
Paradigm BioCapital Advisors LP$209.79M5.84%
Vanguard Group Inc$196.48M5.47%
Jennison Associates LLC$182.60M5.08%
Morgan Stanley$167.10M4.65%
Janus Henderson Group PLC$157.22M5.11%
Driehaus Capital Management LLC$96.00M2.67%
Assenagon Asset Management S.A.$92.34M2.57%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 18, 2026Azamian Bobak R.
CEO
SellCommon Stock$801.6K-12K
-20.45%
45,385
0.10% of shares
medium
Mar 19, 2026Azamian Bobak R.
CEO
SellCommon Stock$801.6K-12K
-26.36%
33,421
0.08% of shares
medium
Mar 17, 2026Azamian Bobak R.
CEO
SellCommon Stock$761.7K-11K
-16.13%
57,052
0.13% of shares
medium
Jan 2, 2026Whitfield Dianne C.
Executive
SellCommon Stock$655.5K-8K
-24.43%
25,121
0.06% of shares
medium
Jun 15, 2026Link William J Phd
Director
SellCommon Stock$655.1K-11K
-8.86%
108,714
0.25% of shares
medium
Mar 4, 2026Neervannan Seshadri
Executive
SellCommon Stock$641.4K-8K
-10.57%
70,817
0.16% of shares
medium
Mar 16, 2026Link William J Phd
Director
SellCommon Stock$578.3K-8K
-6.69%
116,825
0.27% of shares
medium
Jan 2, 2026Whitfield Dianne C.
Executive
SellCommon Stock$457.7K-6K
-14.67%
33,243
0.08% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Tang Capital Management, LLCPassive13G/A—1,188,624—
Prudential Financial IncPassive13G/A—1,836,321—
Janus Henderson Group PLCPassive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
TARS——87650L103—